Capricor Therapeutics Stock Short Interest Falls to 37.37%

Capricor Therapeutics short interest was 37.37% of the float on September 15th, according to new data we received from Benzinga. Short interest totaled 19,680,648 shares, which was a decrease of -11.28% from August 31st.

It is estimated that it would take 5.92 days for short sellers to buy back their shares, with current trading volumes.

Capricor Therapeutics Hedge Fund Activity

We have seen 93 institutional investors add shares of Capricor Therapeutics stock to their portfolio, and 78 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• TANG CAPITAL MANAGEMENT LLC added 2,399,900 shares (+141.2%) to their portfolio in Q2 2026, for an estimated $57,789,591
• BOXER CAPITAL MANAGEMENT, LLC added 805,156 shares (+136.5%) to their portfolio in Q2 2026, for an estimated $19,388,156
• SOLEUS CAPITAL MANAGEMENT, L.P. added 761,737 shares (+inf%) to their portfolio in Q2 2026, for an estimated $18,342,626
• POINT72 ASSET MANAGEMENT, L.P. removed 726,456 shares (-88.5%) from their portfolio in Q2 2026, for an estimated $17,493,060
• BLACKROCK, INC. added 723,246 shares (+21.1%) to their portfolio in Q2 2026, for an estimated $17,415,763
• GOLDMAN SACHS GROUP INC added 666,155 shares (+73.0%) to their portfolio in Q2 2026, for an estimated $16,041,012
• JANE STREET GROUP, LLC removed 566,081 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $13,631,230

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

Capricor Therapeutics Insider Trading Activity

Capricor Therapeutics insiders have traded $CAPR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $CAPR stock by insiders over the last 6 months:

• KAREN KRASNEY (EVP, GENERAL COUNSEL) has made 0 purchases and 4 sales selling 50,000 shares for an estimated $1,551,705.
• ANTHONY BERGMANN (CHIEF FINANCIAL OFFICER) has made 0 purchases and 4 sales selling 50,000 shares for an estimated $1,551,698.

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Investivoq API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.